{"id":8667,"date":"2021-12-17T01:52:52","date_gmt":"2021-12-17T06:52:52","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/glp-1-7-37-cas-106612-94-6-herhangi-bir-yan-etki-olmaksizin-glikoza-bagimli-bir-sekilde-kan-sekerini-dusurur\/"},"modified":"2021-12-17T01:52:52","modified_gmt":"2021-12-17T06:52:52","slug":"glp-1-7-37-cas-106612-94-6-herhangi-bir-yan-etki-olmaksizin-glikoza-bagimli-bir-sekilde-kan-sekerini-dusurur","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/tr\/product\/glp-1-7-37-cas-106612-94-6-herhangi-bir-yan-etki-olmaksizin-glikoza-bagimli-bir-sekilde-kan-sekerini-dusurur\/","title":{"rendered":"GLP-1 (7-37) CAS 106612-94-6, herhangi bir yan etki olmaks\u0131z\u0131n glikoza ba\u011f\u0131ml\u0131 bir \u015fekilde kan \u015fekerini d\u00fc\u015f\u00fcr\u00fcr"},"content":{"rendered":"

GLP-1 (7-37) CAS 106612-94-6 Herhangi bir yan etki olmaks\u0131z\u0131n daha d\u00fc\u015f\u00fck kan \u015fekeri seviyeleri<\/strong><\/h2>\n

\u00dcr\u00fcn Ad\u0131: H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU- PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-ARG-GLY-OH\/ GLP-1 (7-37)
\nE\u015f anlaml\u0131lar: Insulinotropin (insan);Peptid GLP-1 (insan glukozunu d\u00fc\u015f\u00fcren peptid) -1);Glp-I (7-37);Glukagon benzeri peptit I (7-37);Glukagon ile ilgili peptit (oncorhynchus kisutch), 3-L-glutamik asit-6-L-fenilalanin-9-L-aspartik asit-12-L-serin-15-L-glutamik asit-16-glisin-21-L-izol\u00f6sin-24-L-alanin-27-L-valin-28-L-lisin-31-glisin-;Tglp- 1;GLP-1, 7-37;Preproglukagon 78-108
\nCAS: 106612-94-6
\nMF: C151H228N40O47
\nMW: 3355.67
\nEINECS:
\n\u00dcr\u00fcn Kategorileri: peptidler pharm; peptit
\nMol Dosya: 106612-94-6.mol<\/p>\n

GLP-1 (7-37) CAS 106612-94-6 Kimyasal \u00d6zellikler<\/strong>
\nyo\u011funluk 1.48\u00b10.1 g\/cm3(Tahmini)< &>depolama s\u0131cakl\u0131\u011f\u0131 \u221220\u00b0C
\nSuda \u00c7\u00f6z\u00fcn\u00fcrl\u00fck Suda 2mg\/ml'de \u00e7\u00f6z\u00fcn\u00fcr
\nCAS Veri Taban\u0131 Referans\u0131 106612-94-6<\/p>\n

GLP-1'in \u0130\u015flevi ve Uygulamas\u0131 (7-37) CAS 106612-94- 6<\/strong>
\nHumanglukagon benzeriPeptid -1(GLP-1), GLP-1'in \u00e7oklu i\u015flevlerine ek olarak, herhangi bir olumsuz reaksiyon olmaks\u0131z\u0131n kan \u015fekerini glikoza ba\u011f\u0131ml\u0131 bir \u015fekilde d\u00fc\u015f\u00fcrmede g\u00fc\u00e7l\u00fc olan, 30 amino asitli k\u00fc\u00e7\u00fck bir polipeptittir. , \u015feker hastal\u0131\u011f\u0131n\u0131 iyile\u015ftirmede bir ara\u015ft\u0131rma noktas\u0131 haline gelir. Bununla birlikte, klinik uygulamas\u0131n\u0131 ger\u00e7ekle\u015ftirmek i\u00e7in, in vivo olarak k\u0131sa yar\u0131 \u00f6mr\u00fc sorununu \u00e7\u00f6zmek acildir. Bu nedenle, GLP-1'in \u00c7in'deki ve yurtd\u0131\u015f\u0131ndaki ara\u015ft\u0131rma ve klinik uygulamas\u0131na ili\u015fkin en son geli\u015fmelerin \u00f6nceki \u00e7al\u0131\u015fmalara dayal\u0131 olarak g\u00f6zden ge\u00e7irilmesi, ara\u015ft\u0131rmac\u0131lar ve sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131 i\u00e7in GLP-1 ile ilgili ila\u00e7lar\u0131n geli\u015ftirilmesinde referans sa\u011flayacakt\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"

\u00dcr\u00fcn Ad\u0131: H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE -ALA-TRP-LEU-VAL-LYS-GLY-ARG-GLY-OH\/GLP-1 (7-37)
\nCAS: 106612-94-6
\nMF: C151H228N40O47
\nMW: 3355.67< &>Mol Dosyas\u0131: 106612-94-6.mol<\/p>\n","protected":false},"featured_media":2303,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[],"product_tag":[1073],"class_list":{"0":"post-8667","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_tag-glp-1-7-37-cas-106612-94-6-reduce-blood-sugar-in-a-glucose-dependentmanner-without-any-adverse-reactions-tr","7":"desktop-align-left","8":"tablet-align-left","9":"mobile-align-left","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product\/8667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/comments?post=8667"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/media\/2303"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/media?parent=8667"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product_brand?post=8667"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product_cat?post=8667"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product_tag?post=8667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}